Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed Start Ovarian Stimulation with Ganirelix
NCT01614067Phase 4Terminated
- Sponsor
- University of California, San Francisco
- Start
- May 2012
- Primary completion
- Jul 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ganirelix in infertility, Diminished Ovarian Reserve (DOR), sponsored by University of California, San Francisco. Started May 2012; status: terminated.
02
Drugs
ganirelix
03
Conditions
infertilityDiminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT01614067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01614067.